METFORMIN USE AND THE RATES OF DEVELOPMENT OF GESTATIONAL DIABETES MELLITUS (GDM) IN POLYCYSTIC OVARY SYNDROME (PCOS) GRAVIDAE
Fertility and Sterility(2022)
摘要
Heralded as the “aspirin of the 21st century,” metformin’s role as an insulin sensitizer has expanded its clinical uses beyond Type 2 diabetes mellitus to include treatment for prediabetes mellitus, PCOS, and GDM [1]. However, metformin’s role in the treatment of pregnant women with PCOS and its effects on often accompanying pregnancy co-morbidities, such as GDM, remain uncertain [2]. Some studies have shown that in PCOS, use of metformin throughout pregnancy is associated with up to a 10-fold reduction in GDM [3] while others have shown metformin does not prevent gestational diabetes [4] but does result in higher rates of obesity and insulin resistance in the offspring [5,6].
更多查看译文
关键词
polycystic ovary syndrome,metformin,diabetes mellitus,pcos
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要